# Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine

> **NCT01841671** · PHASE4 · UNKNOWN · sponsor: **University of Chile** · enrollment: 570 (estimated)

## Conditions studied

- Polio

## Interventions

- **BIOLOGICAL:** IPV
- **BIOLOGICAL:** bOPV
- **BIOLOGICAL:** mOPV type 2
- **BIOLOGICAL:** Rotarix

## Key facts

- **NCT ID:** NCT01841671
- **Lead sponsor:** University of Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2014-05
- **Final completion:** 2014-06
- **Target enrollment:** 570 (ESTIMATED)
- **Last updated:** 2014-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01841671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01841671, "Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01841671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*